Monarch eTNS for Pediatric ADHD Treatment
The Monarch eTNS (external Trigeminal Nerve Stimulation) device is indicated as a standalone therapy (monotherapy) for the reduction of pediatric ADHD's unwanted concerns. It is approved for patients ages 7 through 12 years old. The device is used at home under the supervision of a caregiver during periods of sleep.
Ideal patients for this ADHD treatment are children who:
-
Cannot tolerate/use stimulants due to side effects or medical contraindications
-
Parents/caregivers who do not want to use medication
-
Patients who, despite being on stimulants, have only a partial response or side effects that prevent dose increases
Additional indications and age groups are being studied, including ADHD teens and adults. Preliminary data suggests eTNS may be helpful for Autistic children who experience uncomfortable distractibility, impulsivity, inattention, and/or anxiety.
The device is FDA approved so it should be covered at least partially by insurance (we will help with this).
The most common side effects observed with eTNS use are: drowsiness, an increase in appetite, trouble sleeping, teeth clenching, headache and fatigue. No serious adverse events have been associated with use of the device.